Leadiant Biosci Inc patents expiration
1. Abelcet patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5616334 | LEADIANT BIOSCI INC | Low toxicity drug-lipid systems |
Apr, 2014
(10 years ago) | |
| US6406713 | LEADIANT BIOSCI INC | Methods of preparing low-toxicity drug-lipid complexes |
Jun, 2019
(4 years ago) | |
Drugs and Companies using AMPHOTERICIN B ingredient
Market Authorisation Date: 20 November, 1995
Treatment: NA
Dosage: INJECTABLE, LIPID COMPLEX;INJECTION
More Information on Dosage
ABELCET family patents
2. Carnitor patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6696493 | LEADIANT BIOSCI INC | Treating chronic uremic patients undergoing periodic dialysis |
Jan, 2021
(3 years ago) | |
| US6335369 | LEADIANT BIOSCI INC | Treating chronic uremic patients undergoing periodical dialysis |
Jan, 2021
(3 years ago) | |
| US6429230 | LEADIANT BIOSCI INC | Treating chronic uremic patients undergoing periodical dialysis |
Jan, 2021
(3 years ago) | |
Drugs and Companies using LEVOCARNITINE ingredient
Market Authorisation Date: 16 December, 1992
Treatment: Use of levocarnitine in prevention and treatment of carnitine deficiency in patients with end stage renal disease who are undergoing dialysis
Dosage: INJECTABLE;INJECTION
More Information on Dosage
CARNITOR family patents